Literature DB >> 31345524

Pituitary Tumors in Pregnancy.

Wenyu Huang1, Mark E Molitch2.   

Abstract

Pituitary adenomas are common. The impact of pituitary tumors on fertility are mainly caused by oversecretion and/or undersecretion of pituitary hormones or compression of pituitary stalk and normal pituitary tissue by the tumor. Diagnosing and managing pituitary tumors during pregnancy involve many challenges, including the effect of hormone excess or deficiency on pregnancy outcome, changes in the pituitary or pituitary-related hormones, changes in tumor size, and the impact of various treatments of pituitary tumors on maternal and fetal outcomes. This article discusses the diagnosis and treatment of patients with prolactinomas, acromegaly, Cushing disease, and other pituitary tumors during pregnancy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acromegaly; Cushing disease; Pituitary tumor; Pregnancy; Prolactinoma

Mesh:

Year:  2019        PMID: 31345524     DOI: 10.1016/j.ecl.2019.05.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

Review 1.  Do nothing but observe microprolactinomas: when and how to replace sex hormones?

Authors:  Vivien Bonert
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 2.  Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines.

Authors:  Na Tosha N Gatson; Maria L Boccia; Kerianne R Taylor; Jada K O Mack; Ekokobe Fonkem
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

Review 3.  Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research.

Authors:  Jessica H Lee; David J Torpy
Journal:  Rev Endocr Metab Disord       Date:  2022-07-11       Impact factor: 9.306

Review 4.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

5.  Persistent vs Recurrent Cushing's Disease Diagnosed Four Weeks Postpartum.

Authors:  Leena Shah; Emily V Nosova; Joshua B Bederson; Khadeen Christi Cheesman
Journal:  Case Rep Endocrinol       Date:  2022-08-13

Review 6.  Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma.

Authors:  Noriaki Fukuhara; Mitsuru Nishiyama; Yasumasa Iwasaki
Journal:  Cancers (Basel)       Date:  2022-07-24       Impact factor: 6.575

Review 7.  Treatment of Prolactinoma.

Authors:  Warrick J Inder; Christina Jang
Journal:  Medicina (Kaunas)       Date:  2022-08-13       Impact factor: 2.948

Review 8.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

9.  The Incidence of Pregnancy-Associated Cushing's Disease and Its Relation to Pregnancy: A Retrospective Study.

Authors:  Keyun Tang; Lin Lu; Ming Feng; Hanlin Zhang; Kang Chen; Xu Sun; Huijuan Zhu; Renzhi Wang; Zhaolin Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-29       Impact factor: 5.555

10.  Management of sellar and parasellar tumors becoming symptomatic during pregnancy: a practical algorithm based on multi-center experience and systematic literature review.

Authors:  Matteo Zoli; Federica Guaraldi; Cesare Zoia; Emanuele La Corte; Sofia Asioli; Daniele Bongetta; Arianna Rustici; Diego Mazzatenta
Journal:  Pituitary       Date:  2020-11-17       Impact factor: 4.107

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.